COVID-19 Infection | Norton Healthcare

Indication: COVID-19 Infection

Phase 2, Randomized, Double-Blind Placebo Controlled Study of Intravenous Abatacept in the Treatment of Hospitalized COVID-19 Participants with Respiratory Compromise

Respiratory complications

Drug Study

Principal Investigator: Paul Schulz, M.D.
Norton Infectious Diseases Institute

Sponsor: Bristol-Myers Squibb (BMS)

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.